Probiotics and Microbiota-Derived Molecules for Inflammation, Neuroinflammation and Mood Disorders: Volume II

A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Applied Biosciences and Bioengineering".

Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 3571

Special Issue Editor

Special Issue Information

Dear Colleagues,

Further to the success of the Special Issue of Polymers "Probiotics and Microbiota-Derived Molecules for Inflammation, Neuroinflammation and Mood Disorders", we are delighted to open a new Special Issue entitled "Probiotics and Microbiota-Derived Molecules for Inflammation, Neuroinflammation and Mood Disorders: Volume II".

Many studies support the existence of a relationship between the ecosystem of microorganisms that populate the gut and health status. The microbiota plays a crucial role in stress, anxiety, learning and memory, addiction, sexual behaviour, social interaction and depression, as well as in neuroinflammation and neurodegeneration.

The microbiota–gut–brain axis is an integrated system of tissues and organs communicating through a complex multidirectional manner via neural, endocrine, circulatory pathways in order to preserve homeostasis.

Dietary ingestion of probiotics and prebiotics affects the gut microbiota composition and reveals the key role played by specific metabolites also in brain health. Microbiota-derived peptides participate in regulating the gut–brain axis.

Some effects and mechanisms of probiotics can be similar to those of drugs and may provide suggestions for future interventions. Manipulation of the microbiota can represent a promising therapeutic strategy for mood disorders.

Prof. Dr. Giovanna Traina
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • probiotic
  • inflammation
  • neuroinflammation
  • mood disorders
  • anxiety
  • depression
  • microbiota–gut–brain axis
  • gut peptides

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

12 pages, 435 KiB  
Review
EEG Changes Related to Gut Dysbiosis in Diabetes—Review
by Roxana Toderean, Mihai Dimian and Claudiu Cobuz
Appl. Sci. 2021, 11(24), 11871; https://0-doi-org.brum.beds.ac.uk/10.3390/app112411871 - 14 Dec 2021
Viewed by 3061
Abstract
Humans are facing a devastating epidemic of metabolic syndrome that is linked to the worldwide dramatic increase in obesity and diabetes. Significant evidence suggests that the intestinal microbiota plays a major role in the pathogenesis of metabolic diseases. Due to the gut–brain axis [...] Read more.
Humans are facing a devastating epidemic of metabolic syndrome that is linked to the worldwide dramatic increase in obesity and diabetes. Significant evidence suggests that the intestinal microbiota plays a major role in the pathogenesis of metabolic diseases. Due to the gut–brain axis link, dysbiosis in the gut microbiota have been demonstrated in both metabolic and neurological disease. Increasing evidence suggests that the gut microbiota is very important in maintaining health and changes in its composition may contribute to psychiatric and neurodegenerative disorders. It is also in research that changes in microbiota composition profile due to diabetes are modulated by the vagus nerve. Therefore, it is plausible that disruptions in the gut microbiota may be captured through electroencephalography signaling. Several studies which used standard methods of signal processing have highlighted some changes in electroencephalographic rhythms on patients with diabetes. Full article
Show Figures

Figure 1

Back to TopTop